Likewise, in MASLD, chronic inflammation plays a pivotal role in disease progression, and biomarkers such as IL-6, TNF-α, and C-reactive protein reflect hepatic inflammation and are crucial indicators of disease severity, correlating with liver injury, fibrogenesis, and the development of cirrhosis [41,42]. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.